M Giordano Selected Research

Neoplasms (Cancer)

1/2022	Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study.
10/2019	C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer?
1/2014	A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.
4/2012	Probiotics in the gastrointestinal diseases of the elderly.
3/2011	XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study.
8/2007	[Diagnostic and therapeutic guidelines for entero-cutaneous fistulas. Personal experience and literature review].
7/2006	Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study.
3/2005	Glutathione reductase inhibition and methylated arsenic distribution in Cd1 mice brain and liver.
9/2002	Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Giordano Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 09/2002
4	Breast Neoplasms (Breast Cancer) 01/2017 - 04/2000
4	Infections 04/2012 - 11/2000
3	Proteinuria 10/2009 - 07/2001
2	Diarrhea 01/2022 - 04/2012
2	Vomiting 01/2022 - 01/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2002
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2019
2	Pain (Aches) 01/2022 - 04/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 11/2009
2	Body Weight (Weight, Body) 01/2020 - 01/2017
2	Inflammation (Inflammations) 10/2018 - 01/2008
2	Heart Failure 01/2018 - 07/2001
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2017 - 07/2001
2	Hypothyroidism 10/2013 - 02/2006
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2012 - 08/2007
2	Malignant Mesothelioma 03/2011 - 07/2006
2	Type 2 Diabetes Mellitus (MODY) 10/2009 - 05/2000
2	Carcinoid Tumor (Carcinoid) 10/2007 - 06/2006
2	Carcinoma (Carcinomatosis) 02/2006 - 09/2002
2	Peripheral Nervous System Diseases (PNS Diseases) 03/2005 - 07/2001
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2005 - 12/2002
2	Multiple Myeloma 01/2003 - 04/2000
2	Crohn Disease (Crohn's Disease) 12/2001 - 05/2001
2	HIV Infections (HIV Infection) 11/2000 - 11/2000
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Nausea 01/2022
1	Pigmented Nevus (Melanocytic Nevus) 01/2022
1	Ischemia 10/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2018
1	Ischemic Stroke 10/2018
1	Stroke (Strokes) 10/2018
1	Chronic Renal Insufficiency 03/2018
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Cognitive Dysfunction 01/2017
1	Memory Disorders (Memory Loss) 03/2016
1	Cleft Palate (Palate, Cleft) 09/2015
1	Intellectual Disability (Idiocy) 09/2015
1	Hearing Loss (Hearing Impairment) 09/2015
1	Intussusception 01/2014
1	Abdominal Pain (Pain, Abdominal) 01/2014
1	Febrile Neutropenia 01/2014
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2013
1	Osteoblastoma 10/2012
1	Neck Pain (Cervicalgia) 10/2012
1	Scoliosis 10/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2012

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2017 - 11/2000
3	Prednisone (Sone)FDA LinkGeneric 01/2022 - 04/2000
3	gamma-Aminobutyric Acid (GABA)IBA 01/2020 - 02/2012
3	Proteins (Proteins, Gene)FDA Link 03/2016 - 01/2008
3	ArsenicIBA 03/2016 - 11/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2012 - 05/2003
3	AlbuminsIBA 10/2009 - 07/2001
3	Immunoglobulin G (IgG)IBA 10/2009 - 01/2001
2	Glutamic Acid (Glutamate)FDA Link 01/2020 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 10/2018 - 09/2009
2	Growth Hormone (Somatotropin)IBA 03/2018 - 09/2015
2	Glucose (Dextrose)FDA LinkGeneric 03/2016 - 10/2000
2	Drinking WaterIBA 03/2016 - 03/2005
2	AsbestosIBA 03/2011 - 07/2006
2	Fibrinogen (Factor I)FDA Link 01/2008 - 07/2001
2	Serum AlbuminIBA 01/2008 - 07/2001
2	ElectrolytesIBA 08/2007 - 03/2000
2	DNA (Deoxyribonucleic Acid)IBA 07/2006 - 09/2002
2	Epirubicin (Ellence)FDA LinkGeneric 07/2001 - 04/2000
2	Fluorouracil (Carac)FDA LinkGeneric 07/2001 - 04/2000
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2001 - 04/2000
1	binimetinibIBA 01/2022
1	Abiraterone AcetateIBA 01/2022
1	encorafenibIBA 01/2022
1	abirateroneIBA 01/2022
1	Cetuximab (Erbitux)FDA Link 01/2022
1	HerbicidesIBA 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	PotassiumIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2018
1	Retinoid X Receptors (Retinoid X Receptor)IBA 10/2018
1	HX 600IBA 10/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018
1	coenzyme Q10 (CoQ10)IBA 01/2017
1	ubiquinone 6IBA 01/2017
1	Methylcellulose (BFL)IBA 01/2017
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2017
1	Vinorelbine (Navelbine)FDA LinkGeneric 12/2016
1	Capecitabine (Xeloda)FDA Link 12/2016
1	Insulin ReceptorIBA 03/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2014
1	Thyroid HormonesIBA 10/2013
1	Galectin 1 (LGALS1)IBA 06/2013
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2012

Therapy/Procedure

13	Therapeutics 01/2022 - 04/2000
9	Drug Therapy (Chemotherapy) 01/2022 - 04/2000
2	Radiotherapy 08/2007 - 09/2002
2	Operative Surgical Procedures 08/2007 - 08/2001
1	Castration 01/2022
1	Uterine Artery Embolization 01/2018